FIGO regularly issues statements and joint statements.

On international Women Human Rights Defenders Day, FIGO stands with partners and allies to support the launch a new set of ...

FIGO’s Improving access to essential medicines to reduce postpartum haemorrhage (PPH) morbidity and mortality (IAP) project ...

FIGO’s Self-Management of Abortion (SMA) Project, which concluded in May 2024, worked to implement WHO Abortion Guideline on ...

"This protocol represents a significant step forward in standardising care for women recovering from vesicovaginal fistula ...

FIGO’s Combatting Post-Partum Hemorrhage (PPH) project aims to provide technical support to selected regional and national ...

This World Prematurity Day, FIGO calls on healthcare providers, policymakers, and communities to champion better care for ...

FIGO and the World Health Organization (WHO) are collaborating to enhance family planning care globally, by increasing ...

Postpartum Haemorrhage (PPH) is the leading cause of maternal mortality in low-income countries. The most common cause of PPH ...

Project leads: Professor Sean Kehoe, Past Chair and current member of the FIGO Committee on Women's Cancer; Professor Joanna ...

FIGO’s Accelerating Measurable Progress and Leveraging Investments for Postpartum Haemorrhage Impact (AMPLI-PPHI) project ...

Background: Post-partum haemorrhage (PPH) is the most significant direct cause of maternal mortality in low-resource ...